MTOR and glioblastoma: Unlike the findings from Zhang and colleagues reporting that vitexin treatment resulted in inhibition of the Akt/mTOR signaling pathway in human glioblastoma LN-18 cells [14], the results of the present study showed a reduction in the activity of the JAK/STAT signaling pathway following vitexin treatment, which may be attributed to different cell lines.